Database | Recombinant Antibodies And Mimetics Database

What can we help you find?

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

74911-74920 of 84783 results

Catalogue Number:

A27199PM

Category:

PKM1/2 Rabbit PolymAb?

Target:	PKM
Target Alias Names:	PK3, TCB, p58, OIP3, PKM2, CTHBP, THBP1, HEL-S-30
Species Reactivity:	Human, Mouse, Rat
Applications:	Immunofluorescence, Western Blot
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	PBS containing 50% glycerol and 0.05% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

75243

Category:

PKN3 (F6S5C) Rabbit mAb

Target:	PKN3
Target Alias Name:	PKN3
Species Reactivity:	Human
Application:	Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Animal-Derived Biomaterials Used:	BSA
Sequence Available	Yes
Original Discovery Method	Immunization
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A19545

Category:

PKR/EIF2AK2 Rabbit mAb

References available

Target:	EIF2AK2
Target Alias Names:	PKR, PRKR, DYT33, LEUDEN, EIF2AK1, PPP1R83, PKR/EIF2AK2
Species Reactivity:	Human
Application:	Western Blot
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A19252

Category:

PLA2G2A Rabbit mAb

References available

Target:	PLA2G2A
Target Alias Names:	MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2, PLA2G2A
Species Reactivity:	Human, Mouse, Rat
Application:	Western Blot
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A19258

Category:

Placental lactogen (CSH1) Rabbit mAb

Target:	CSH1
Target Alias Names:	PL, CSA, CS-1, CSMT, GHB3, hCS-1, hCS-A, Placental lactogen (CSH1)
Species Reactivity:	Human
Application:	Immunofluorescence
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A19738

Category:

PLC beta 3 (PLCB3) Rabbit mAb

Target:	PLCB3
Target Alias Names:	SMDCD, PLC beta 3 (PLCB3)
Species Reactivity:	Human
Application:	Western Blot
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A8899

Category:

PLC gamma 1 (PLCG1) Rabbit mAb

References available

Target:	PLCG1
Target Alias Names:	PLC1, NCKAP3, PLC-II, PLC148, PLCgamma1, PLC gamma 1 (PLCG1)
Species Reactivity:	Human, Mouse, Rat
Application:	Western Blot
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A25017

Category:

PLC gamma 2 (PLCG2)?Rabbit mAb

Target:	PLCG2
Target Alias Names:	FCAS3, APLAID, PLC-IV, PLC-gamma-2
Species Reactivity:	Human, Mouse
Application:	Western Blot
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	PBS with 0.09% Sodium azide, 0.05% BSA, 50% glycerol, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

34264

Category:

PLCγ2 (E7L6G) Rabbit mAb

References available

Target:	PLCg2
Target Alias Name:	PLCG2
Species Reactivity:	Human, Mouse
Application:	Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Animal-Derived Biomaterials Used:	BSA
Sequence Available	Yes
Original Discovery Method	Immunization
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

97211

Category:

PLCγ2 (F9L8Z) Rabbit mAb

Target:	PLCg2 mouse
Target Alias Name:	PLCG2
Species Reactivity:	Human, Mouse
Applications:	Immunofluorescence, Immunoprecipitation, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Animal-Derived Biomaterials Used:	BSA
Sequence Available	Yes
Original Discovery Method	Immunization
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Viewing 74911-74920 of 84783 results

Previous
1
…
7,491
7,492
7,493
…
8,479
Next

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.